
Empirico
Empirico develops a biotechnology platform that examines genomics data to develop drugs. Read more
Empirico develops a biotechnology platform that examines genomics data to develop drugs. Read more
Empirico develops a biotechnology platform that examines genomics data to develop drugs. Read more
CEO
Omri Gottesman
Genoox is one of Empirico's top competitors. Genoox was founded in 2014 in Palo Alto, California. Genoox operates in the Health Care Technology industry. Genoox generates $1M less revenue than Empirico.
No recent acquisitions found related to Empirico
Since Empirico was founded in 2017, it has participated in 2 rounds of funding. In total Empirico has raised $29.5M. Empirico's last funding round was on Jan 2020 for a total of $17.0M
No recent investments found related to Empirico